We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
27/1/2017 11:41 | When it does turn it will quick. Obviously rise to 270p was way overdone but this drop is also way overdone. It is a growth stock with huge potential. | ileeman | |
27/1/2017 11:39 | Hybridan have been total numpties in advising the company IMHO. Absolute clowns. Part of their advice should be expectation management and they have been found to be woefully inept. The board themselves appear to be a bit damp behind the ears too. A heavyweight addition to the BOD is called for to steer this fledgling company. Mkt cap of just a touch over £13m! If they manage to steer a clear course then that will begin to look silly. AIMHO. | kemche | |
27/1/2017 11:35 | Bought some more. Got to bounce soon. | ileeman | |
27/1/2017 11:32 | Not long then for the interims, should prove interesting . | bahiflyer | |
27/1/2017 11:16 | AISHAH, that was more a symptom of the share price rising so fast at the time. They do a weighted average, I was peeved off with that at the time. They are right numpties for not raising more money above 200p IMHO, that's the management risk that the share price is reflecting. Don't expect results next month to be stellar. | che7win | |
27/1/2017 11:07 | The share price at the last placing of 110p was around 140p. Wonder what the discount would be now if there's another one? Any ideas? | aishah | |
27/1/2017 11:05 | As 110p is support you may see a short term bounce but doubt it will be significant before sold into, unless some new positive newsflow comes through. | ny boy | |
27/1/2017 11:03 | The risk is high here, however I've bought a few at this price. I think I would prefer buying at 80p-£1 as a better risk/reward, I'll only buy more if it falls to around those levels - the chart looks awful. | che7win | |
27/1/2017 11:00 | Yes I would say theres more risk being out at this price and stage of development. | susiebe | |
27/1/2017 10:58 | If it went below £1, I'd buy the company ... LOL! | andyr42 | |
27/1/2017 10:56 | It could move up very quickly on a positive announcement, small down side risk yes, but more upside imho. In any case if you hold and wait for FDA approval of hair product and ST sales in 2nd half, you can see the share price above £2. The capitalization at present is far too low for such a promising outfit. | andyr42 | |
27/1/2017 10:48 | The support at around this 110p is pretty important, a break below could open up a move to under 100p but doubt much lower than 85p The trouble is sentiment has gone from positive to negative following the last rns etc.Also moves can be exaggerated other way due to share illiquidity | ny boy | |
27/1/2017 10:46 | This was the price I was waiting for, thanks! | susiebe | |
27/1/2017 10:46 | yes, i bought a few as gone too far down | andyr42 | |
27/1/2017 10:45 | Double bottom let's see | nw99 | |
27/1/2017 10:44 | Time to buy then | nw99 | |
27/1/2017 10:43 | Dec. 2016 placing announcement ... ("InnovaDerma" or the "Company") Placing InnovaDerma (LON: IDP), a UK developer of 'at-home' and clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation, is pleased to announce that the Company has raised GBP800,000 before expenses through a placing by Hybridan LLP of 727,273 new ordinary shares (the "Placing Shares") at a placing price of 110 pence per share. Use of proceeds The Company has continued to receive strong demand for its products and therefore the key funding priority is to build stock levels at a faster pace to fulfil any increase in demand from various markets in the second half of our financial year in 2017. | andyr42 | |
27/1/2017 10:15 | Good job I sold @ £2.52... :) | potential | |
27/1/2017 09:45 | The company have brought the share price down to a more realistic level and have stopped people jumping in at 200p+Can build from here... | susiebe | |
27/1/2017 09:35 | So where next? Agree the management needs to step up and rescue the SP, perhaps it is deliberate to let the share price slide for, as some put it, another bout of fund raising? Fallen too far for comfort. | andyr42 | |
27/1/2017 08:16 | No real growth will come without funding. I am waiting to see how they resolve that. | luminoso | |
27/1/2017 08:12 | Damaged as in confidence in the BoD has been lost.Good product + good management = $$$$Good product + poor management = $$When investing, the trend is your friend. It tells me that now is not the right time to invest. | longshanks | |
27/1/2017 08:02 | Damaged as in botched placing | zoolook | |
27/1/2017 06:55 | Damaged? What do you mean?Its a great product selling well in UKAnd could expand very quickly in these (GnC?) Stores in america | dmk1198 | |
27/1/2017 00:34 | On would expect some solid support at £1.10 (the price of the December placing).However, given just how weak support has been, i wouldn't be surprised to see £1.10 support disappear quite quick and for the psychological support point at £1 to be tested.I will buy in at some point but definitely not yet: far too early and there is no rush. Quite happy to watch this one out.You are right Dibbs that at some point the upside on this stock will be realised. However, when a stock is as damaged as this one, then that turnaround could take some time. | longshanks |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions